Asif Ali - 18 Apr 2022 Form 4 Insider Report for Protagonist Therapeutics, Inc (PTGX)

Role
Chief Financial Officer
Signature
/s/ Asif Ali
Issuer symbol
PTGX
Transactions as of
18 Apr 2022
Net transactions value
$0
Form type
4
Filing time
19 Apr 2022, 19:48:56 UTC
Next filing
18 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PTGX Common Stock Award $0 +13,750 $0.000000 13,750 18 Apr 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PTGX Stock Option (right to buy) Award $0 +82,500 $0.000000 82,500 18 Apr 2022 Common Stock 82,500 $19.19 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents grant of restricted stock units payable solely in shares of the Issuer's common stock that will vest in four annual installments on April 18, 2023, 2024, 2025 and 2026, subject to the Reporting Person's continued service to the Issuer.
F2 The stock option represents a right to purchase a total of 82,500 shares of the Issuer's common stock, one quarter of which will vest on April 18, 2023, with the remaining three quarters vesting in equal monthly installments through April 18, 2026, subject to the Reporting Person's continued service to the Issuer.